Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Developing a prototype for rapidly deployable ventilator


An interdisciplinary team of engineers and medics is addressing ways to increase the UK’s capacity for ventilator manufacture.

Shared Parental Leave

Staff development

An interview about one couple's experience of shared parental leave at the University of Oxford.

International Women’s Day Wikipedia Editathon 2020

Staff development

To celebrate International Women’s Day 2020, this year NDCN teamed up with the Radcliffe Department of Medicine to host a Wikipedia Editathon

School students help with sleep research

Ophthalmology Public engagement

A group of students got a taste of research at Oxford earlier this month when they spent a day analysing data at our Sleep and Circadian Neuroscience Institute.

Wolfson Building housing stroke centre opens

Event Research

Research into strokes and vascular dementia took a major step forward on Thursday 5 March with the official opening of our Wolfson Centre for the Prevention of Stroke and Dementia (CPSD) based at the new Wolfson Building.

Gene therapy shows promise in tackling common cause of childhood blindness

Ophthalmology Research

The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.

Gift boosts research into UK’s biggest cause of sight loss

Ophthalmology Research

£277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.

Improving epilepsy treatment in Africa

Clinical Neurology

The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded £4.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.

Our researchers test ‘Viagra’ drug to prevent recurrent strokes

Research Stroke & Dementia

Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.

Testing epilepsy drug on people with Alzheimer's disease

Clinical Neurology Research

Dr Arjune Sen is leading a new six-month trial funded by the MRC Confidence in Concept scheme. The study is known as IliAD (Investigation of Levetiracetam in Alzheimer's Disease).

Timothy Behrens recognised in prestigious Blavatnik Awards for Young Scientists

Award Integrative Neuroimaging

Professor Timothy Behrens has been recognised for ground-breaking contributions to translational research.

Parkinson's research group receive data sharing award

Award Clinical Neurology

The Oxford Parkinson's Disease Centre received the award for their contribution to the Critical Path for Parkinson’s initiative

Angela Vincent honoured for excellence in epilepsy research

Award Clinical Neurology

Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.

Highly Cited Researchers


Eight NDCN academics have been named in the 2019 list from Web of Science

Ground-breaking study for Huntington’s disease under way

Clinical Neurology Research

NDCN’s Associate Professor Andrea Nemeth is leading the Oxford part of a clinical trial for Hungtinton’s disease.

Sarosh Irani wins Graham Bull Prize

Award Clinical Neurology

The Graham Bull Prize in Clinical Science / Goulstonian Lectureship is a prestigious annual prize awarded by the Royal College of Physicians

NDCN staff win teaching awards

Award Teaching

The 2019 MSD Teaching Excellence Awards were celebrated in a ceremony at Merton College on Wednesday 23 October.

Oxford is joint top recruiter to drug-resitant epilepsy study

Clinical Neurology

The Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.

Advances made in understanding how eye movements are affected by medication in Parkinson's

Clinical Neurology Publication Research

Our Neurometrology Group has published findings from its OxQUIP study looking at how eye movements are affected by medication in Parkinson's.

Prize for work on gene therapy for retinal diseases

Award Ophthalmology

Dr Kanmin Xue has won the Ruskell Medal from the Worshipful Company of Spectacle Makers

Load More